Idiopathic Short Stature: What to Expect from Genomic Investigations
Endocrines · 09.01.2023 · 4 (1) · 1-17
DOI: 10.3390/endocrines4010001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrines, online erschienen am 09.01.2023. Verfasst von Nathalia Liberatoscioli Menezes Andrade und 4 weiteren Autor:innen. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development (CNPq), Coordination of Superior Level Staff Improvement.
Abstract (Originalsprache)
Short stature is a common concern for physicians caring for children. In traditional investigations, about 70% of children are healthy, without producing clinical and laboratory findings that justify their growth disorder, being classified as having constitutional short stature or idiopathic short stature (ISS). In such scenarios, the genetic approach has emerged as a great potential method to understand ISS. Over the last 30 years, several genes have been identified as being responsible for isolated short stature, with almost all of them being inherited in an autosomal-dominant pattern. Most of these defects are in genes related to the growth plate, followed by genes related to the growth hormone (GH)–insulin-like growth factor 1 (IGF1) axis and RAS-MAPK pathway. These patients usually do not have a specific phenotype, which hinders the use of a candidate gene approach. Through multigene sequencing analyses, it has been possible to provide an answer for short stature in 10–30% of these cases, with great impacts on treatment and follow-up, allowing the application of the concept of precision medicine in patients with ISS. This review highlights the historic aspects and provides an update on the monogenic causes of idiopathic short stature and suggests what to expect from genomic investigations in this field.
Förderung
- National Council for Scientific and Technological Development (CNPq)
- Coordination of Superior Level Staff Improvement
Zitieren
APA
Andrade, N. L. M., Cellin, L. P., Rezende, R. C., Vasques, G. A., & Jorge, A. A. L. (2023). Idiopathic Short Stature: What to Expect from Genomic Investigations. Endocrines, 4(1), 1-17. https://doi.org/10.3390/endocrines4010001
Vancouver
Andrade NLM, Cellin LP, Rezende RC, Vasques GA, Jorge AAL. Idiopathic Short Stature: What to Expect from Genomic Investigations. Endocrines. 2023;4(1):1-17. doi:10.3390/endocrines4010001
BibTeX
@article{Andrade2023,
author = {Andrade, Nathalia Liberatoscioli Menezes and Cellin, Laurana Polli and Rezende, Raissa Carneiro and Vasques, Gabriela Andrade and Jorge, Alexander Augusto Lima},
title = {Idiopathic Short Stature: What to Expect from Genomic Investigations},
journal = {Endocrines},
year = {2023},
volume = {4},
number = {1},
pages = {1--17},
doi = {10.3390/endocrines4010001}
}
EUVIMED